Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (31)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  2. HTLV-1-associated myelopathy in Spain

    Journal of Clinical Virology, Vol. 169

  3. Risk Factors for Bacteremia and Its Clinical Impact on Complicated Community-Acquired Urinary Tract Infection

    Microorganisms, Vol. 11, Núm. 8

2022

  1. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

2021

  1. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  2. Current event of emerging viruses: Crimean-Congo hemorrhagic fever virus

    Gaceta Medica de Bilbao, Vol. 118, Núm. 1, pp. 49-53

2020

  1. Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle

    Anaerobe, Vol. 61

  2. The situation of infection in the elderly in Spain: A multidisciplinary opinion document

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 5, pp. 327-349

  3. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. Study of dermatophytes in a third level hospital

    Dermatologia Revista Mexicana, Vol. 63, Núm. 2, pp. 144-151

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  3. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2016

  1. Postbooster antibodies from humans as source of diphtheria antitoxin

    Emerging Infectious Diseases, Vol. 22, Núm. 7, pp. 1265-1267

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2013

  1. Bacteriemias por Staphylococcus coagulasa negativa

    Revista Espanola de Quimioterapia

  2. Bacteriemias por Staphylococcus spp. en mayores de 80 años

    Revista Clinica Espanola